Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Cardiology
Volume 2018 (2018), Article ID 7074104, 4 pages
https://doi.org/10.1155/2018/7074104
Case Report

STEMI in a Young Male after Use of Synephrine-Containing Dietary Supplement

Department of Internal Medicine, Monmouth Medical Center, Long Branch, NJ, USA

Correspondence should be addressed to Dileep Unnikrishnan; moc.liamg@innupeelidrd

Received 24 November 2017; Accepted 18 March 2018; Published 1 April 2018

Academic Editor: Assad Movahed

Copyright © 2018 Dileep Unnikrishnan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Anon, 2017,, http://www.fda.gov/Food/DietarySupplements/GuidanceComplianceRegulatoryInformation/RegulationsLaws/ucm079733.htm.
  2. J. W. Saw, E. Aymong, C. Buller et al., “Non-atherosclerotic spontaneous coronary artery dissection association with predisposing and precipitating conditions and cardiovascular outcomes,” Journal of the American College of Cardiology, vol. 12, no. 63, p. A4, 2014. View at Publisher · View at Google Scholar
  3. J. E. Thomas, J. A. Munir, P. Z. McIntyre, and M. A. Ferguson, “STEMI in a 24-year-old man after use of a synephrine-containing dietary supplement, of a synephrine-containing dietary supplement: a case report and review of the literature,” Texas Heart Institute Journal, vol. 36, no. 6, pp. 586–590, 2009. View at Google Scholar
  4. A. B. Stockton, P. T. Pace, and M. L. Tainter, “Some clinical actions and therapeutic uses of racemic synephrine,” Journal of Pharmacology and Experimental Therapeutics, vol. 41, no. 1, pp. 11–20, 1931. View at Google Scholar
  5. G. C. Schmitt, M. D. Arbo, A. L. Lorensi et al., “Toxicological effects of a mixture used in weight loss products: p-synephrine associated with ephedrine, salicin, and caffeine,” International Journal of Toxicology, vol. 31, no. 2, pp. 184–191, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. C. A. Haller and N. L. Benowitz, “Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids,” New England Journal of Medicine, vol. 343, no. 25, pp. 1833–1838, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. B. G. Schwartz, S. Rezkalla, and R. A. Kloner, “Cardiovascular effects of cocaine,” Circulation, vol. 122, no. 24, pp. 2558–2569, 2010. View at Publisher · View at Google Scholar · View at Scopus